Long-term efficacy and safety of anti-VEGF therapy in retinitis pigmentosa: a case report

Long-term efficacy and safety of anti-VEGF therapy in retinitis pigmentosa: a case report

Abstract Background Retinitis pigmentosa (RP), a neurodegenerative disease, is occasionally accompanied by choroidal neovascularization (CNV) and cystoid macular oedema. It is presently treated with repeated intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents. However, t...

Full description

Bibliographic Details
Main Authors: Manabu Miyata, Akio Oishi, Maho Oishi, Tomoko Hasegawa, Hanako Ohashi Ikeda, Akitaka Tsujikawa
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Ophthalmology
Subjects:
Retinitis pigmentosa
Anti-VEGF therapy
Choroidal neovascularization
Long-term
PRPH2
Online Access:http://link.springer.com/article/10.1186/s12886-018-0914-z

Internet

http://link.springer.com/article/10.1186/s12886-018-0914-z

Similar Items